PPT-Understanding Transplant for Bone Marrow Failure Diseases

Celalettin Ustun MD Rush University Division of HematologyOncologyCell Therapy Director Section of Cell Therapy The Aplastic Anemia and MDS International Foundation A virtual patient and family conference . By. . SOMESHWAR.K. M.PHARM.. II - SEMESTER . . . Department of Pharmaceutics. University College of Pharmaceutical Sciences,. KAKATIYA UNIVERSITY. Dr. Mustafa CETIN. 2. 5. th. . November. 201. 6. . . After the atomic bomb explosion in Japan, ending WW2, many scientists began to explore ways of protecting humans from irradiation. . How haematopoietic stem cell transplant was born:. Brian Boulmay. , . MD. Bone Marrow Failure . Ineffective marrow-poeisis is the final endpoint of many diseases. . Congenital. Acquired . Genetic. Environmental or iatrogenic causes. Congenital marrow failure can present at any age.. Josu. de la . Fuente. Departments of Paediatrics and Haematology. Imperial College London. 25% of paediatric and 10% of young adult patient presenting with aplastic anaemia. Fanconi Anaemia. Median age of presentation 7 years of age. Lauren . Cosolo. , RN, BScN, MN. Outline. Review bone marrow failure and disease. Discuss . Myelodysplastic. syndrome, pathophysiology, clinical presentation, diagnosis, treatment. Discuss Aplastic Anemia, . Professor of Pediatrics, Harvard Medical School. Director, Bone Marrow Failure and Myelodysplastic Syndrome Programs. Jim Connelly, MD. Assistant Professor of Pediatrics, Vanderbilt University Medical Center. Department of Pathology and Laboratory Medicine. Located 2-3655. Hours of Operation: . 8am-6pm M-F . 8am-5pm Saturday. . Follow a . Bone. Marrow from collection to diagnosis. Laboratory. Testing. Diane Hill-Polerecky RN, BSN, MS. Leukemia Transplant Case Manager & Transplant Clinical Projects Coordinator. Nebraska Medicine. Objectives. Define and identify indication for . Hematopoietic Stem Cell Transplant. DB00020 . Protein chemical . formula : . C. 639. H. 1006. N. 168. O. 196. S. 8. Protein . average . weight : . 14434.5000. Description. . :. Sargramostim. is a human recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) expressed in yeast. It is a glycoprotein that is 127 residues. Substitution of Leu23 leads to a difference from native protein. . na. ji. Leukopenia. . Leukopenia. refers to the decrease in the number of white blood cells (WBC) in blood. . Causes of . Leukopenia. Leukopenia. may be caused by various diseases and drugs. Some of these are outlined here:-. Fibrosis Figure Legend: Figure 1 Dense fibrous tissue surrounded by areas of angiectasis is present in bone marrow in a male F344/N male rat from a chronic study. Figure 2 Higher magnification of Fig - tion (Figure 1). Skeletal aging is characterized as a gradual loss of bone mass due to an excess of bone resorption that is not matched by new bone formation. There are two major types of bone Matthew Ware PA-C. Hematology/Oncology, BMT. Froedtert. and the Medical College of Wisconsin Cancer Center. Disclosures. None. Objectives. Understand . basic . labs. Interpreting myeloma labs. Imaging and its role. Part 2. Wendy Blount, DVM. Slide Preparation. Pipette flecks out of the petri dish and put on glass slides immediately. Elevate one end of the slide to let extra blood run . off. Slide Preparation. Pipette flecks out of the petri dish and put on glass slides immediately.